Welcome to LookChem.com Sign In|Join Free

CAS

  • or

338454-32-3

Post Buying Request

338454-32-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

338454-32-3 Usage

Structure

Benzene ring with a bromine atom at the 4th position
Methyl group at the 2nd position
Benzyloxy group attached to the 1st position of the benzene ring

Physical state

Pale yellow to brown colored liquid

Applications

Synthesis of pharmaceutical and agrochemical products
Building block for the preparation of a wide range of organic compounds

Check Digit Verification of cas no

The CAS Registry Mumber 338454-32-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,8,4,5 and 4 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 338454-32:
(8*3)+(7*3)+(6*8)+(5*4)+(4*5)+(3*4)+(2*3)+(1*2)=153
153 % 10 = 3
So 338454-32-3 is a valid CAS Registry Number.

338454-32-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(benzyloxy)-4-bromo-2-methylbenzene

1.2 Other means of identification

Product number -
Other names Benzyl-(4-brom-2-methyl-phenyl)-aether

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:338454-32-3 SDS

338454-32-3Relevant articles and documents

TETRAZOLINONE COMPOUNDS AND APPLICATIONS THEREOF

-

Paragraph 1440-1441, (2016/06/28)

A tetrazolinone compound represented by formula (1): wherein Q represents a 6-membered aromatic heterocyclic group optionally having one or more atoms or groups selected from Group P1, provided that a heteroatom constituting the heterocyclic gr

BIS-(ARYL/HETEROARYL)-METHYLENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE FOR TREATING CANCER

-

Page/Page column 25; 26, (2013/07/05)

The present disclosure relates to novel bis-(aryl/heteroaryl)-methylene compounds of formula (I) having vitamin D receptor agonist and histone deacetylase (HDAC) inhibitory efficacy as well as to methods for reducing or inhibiting the proliferation of can

PYRIMIDINE INHIBITORS OF KINASE ACTIVITY

-

Page/Page column 111, (2010/12/26)

The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts or solvates thereof, wherein G1, R2, R3, R4, R5, n, p, q, Ar1, and Ar2 are defined in the description. The present invention relates also to methods of making said compounds, and compositions comprising said compounds which are useful for inhibiting kinases such as IGF-IR.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 338454-32-3